Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta‐Analysis

BACKGROUND: Overall risks of hepatotoxicity with immune checkpoint inhibitors (ICIs) have yet to be compared in primary liver cancers to other solid tumors. METHODS: We reviewed data from the PubMed, Embase, and Scopus databases, and assessed the risk of hepatotoxicity associated with ICIs. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jianyang, Li, Wang-Zhong, McGrath, Nicole A., Lai, Chunwei Walter, Brar, Gagandeep, Xiang, Yan-Qun, Xie, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097087/
https://www.ncbi.nlm.nih.gov/pubmed/33968750
http://dx.doi.org/10.3389/fonc.2021.650292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097087/
https://www.ncbi.nlm.nih.gov/pubmed/33968750
http://dx.doi.org/10.3389/fonc.2021.650292

Ejemplares similares